Bio Green Med Solution, Inc.
BGMS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | -0.00 | 0.16 | 0.00 |
| FCF Yield | -11.64% | -11.07% | -62.43% | -584.91% |
| EV / EBITDA | 0.10 | -4.01 | -0.35 | 1.54 |
| Quality | ||||
| ROIC | -13.86% | -36.23% | -163.99% | 138.06% |
| Gross Margin | 20.99% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.44 | 0.80 | 40.09 | 0.44 |
| Growth | ||||
| Revenue 3-Year CAGR | -40.73% | -70.07% | 240,914.23% | 350,239.81% |
| Free Cash Flow Growth | 58.90% | 67.48% | -139.45% | 55.79% |
| Safety | ||||
| Net Debt / EBITDA | 3.87 | 3.24 | 0.68 | 1.66 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.05 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 2,071.18 | -19,890.00 | 0.00 | -413,910.00 |